2009-11-10 16:56:06 -

First graph, first sentence of release should read: ...Biostatistical Insourcing Program (sted ...Biostatical Insourcing Program).

The corrected release reads.

BIOBRIDGES, LLC OFFERS STATCONNECT™ BIOSTATISTICAL INSOURCING PROGRAM

Companies Benefit from Dedicated Statistical Team in a Cost Effective Delivery Path

BioBridges, LLC : , a clinical development consultancy serving the biopharmaceutical community, recently launched its Biostatistical Insourcing Program, STATConnect™, to offer its clients an alternative

to costly outsourcing models. This latest offering from BioBridges adds to the already successful Clinical Connect™ Service to help companies span The Clinical Divide™.

STATConnect enables pharmaceutical, biotech and medical device companies to focus on core competencies while shielding them from having to invest in costly infrastructure. BioBridges’ STATConnect delivers a flexible statistical "insourcing" model and an elite statistical team customized by specific project need.

“Working in a virtual pharmaceutical company provides exposure to numerous vendors and a unique perspective for evaluating the services they provide," said Martie Griffin, VP, Quality Assurance & Compliance, Celtic Pharma. "BioBridges’ STATConnect took the time to understand the details and needs of my project, and tailored their services to ensure the desired outcome was achieved. This, coupled with timely, accurate communication resulted in a shortened timeline and cost savings, making for a truly successful engagement.”


STATConnect offers pharmaceutical, biotech and medical device companies a flexible model without a costly infrastructure. The demand for responsive and scalable statistical services is increasing as cumbersome outsourcing models continue to fall short. BioBridges’ STATConnect meets this demand while allowing companies to keep control over their trials.

“I am extremely happy to add high quality and cost effective project statistical solutions to our already successful statistical consulting practice," said Barry Turnbull, Principal Consultant, BioBridges.

"Clients that select STATConnect for their clinical trial statistical analysis needs will greatly benefit from our Insourcing statistical model. Staffed with highly trained, experienced statisticians and statistical programmers, it truly is an extension of their internal clinical trial staff.”


"We've launched the Biostatistical Insourcing program because we saw a gap in the marketplace for a nimble, high quality service," said Andrew Young, Managing Partner, BioBridges. "The team we've assembled has the experience and acumen to successfully meet any Clinical Divide across all therapeutic areas.”


To learn more about how STATConnect can help your company, click here: www.biobridges.com/clinicalConnect/ :



About BioBridges, LLC

BioBridges leverages decades of experience successfully managing clinical trials in a wide range of therapeutic areas. Its Clinical Connect™ practice helps emerging clinical organizations to “build bridges” between all areas of the clinical development lifecycle—from protocol inception, through execution and submission. BioBridges may be reached at www.biobridges.com : or 781.416.0909.



BioBridges, LLCAndrew Young, 781-416-0909Managing Partner ayoung@biobridges.com : mailto:ayoung@biobridges.com